RHÖN-KLINIKUM AG 

05.07.2012 14:32

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.



Notification according to section 26 para. 1 WpHG 

Morgan Stanley & Co International Plc, London, UK, Morgan Stanley UK Group,
London, UK, Morgan Stanley Group (Europe), London, UK, Morgan Stanley
International Limited, London, UK, Morgan Stanley International Holdings
Inc, Delaware, USA, and Morgan Stanley, Delaware, USA notified us pursuant
to section 25a WpHG of the following:

1) On 27 June 2012, Morgan Stanley & Co International Plc fell below the
threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite
1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley &
Co International Plc held 0.07% of the voting rights in RHÖN-KLINIKUM AG
(equals 99,226 voting rights).

From these voting rights a proportion of 0.00% (equals 0 voting rights) is
based on voting rights pursuant to sections 21, 22 WpHG.

In addition, a proportion of 0.06% (equals 85.500 voting rights) is based
on (financial/other) instruments pursuant to section 25 WpHG. From the
voting rights based on instruments pursuant to section 25 WpHG a proportion
of 0.06% (equals 85,500 voting rights) is held indirectly.

In addition, a proportion of 0.01% (equals 13,726 voting rights) is based
on (financial/other) instruments pursuant to section 25a WpHG. From the
voting rights based on instruments pursuant to section 25a WpHG a
proportion of 0.00% (equals 0 voting rights) is held indirectly. The
instruments pursuant to section 25a WpHG are 'Cash-Settled Swaps'
(expiration date: 31 October 2013).

2) On 27 June 2012, Morgan Stanley UK Group fell below the threshold of 5%
of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad
Neustadt a. d. Saale, Germany. On that date Morgan Stanley UK Group held
0.07% of the voting rights in RHÖN-KLINIKUM AG (equals 99,226 voting
rights).

From these voting rights a proportion of 0.00% (equals 0 voting rights) is
based on voting rights pursuant to sections 21, 22 WpHG.

In addition, a proportion of 0.06% (equals 85,500 voting rights) is based
on (financial/other) instruments pursuant to section 25 WpHG. From the
voting rights based on instruments pursuant to section 25 WpHG a proportion
of 0.06% (equals 85,500 voting rights) is held indirectly.

In addition, a proportion of 0.01% (equals 13,726 voting rights) is based
on (financial/other) instruments pursuant to section 25a WpHG. From the
voting rights based on instruments pursuant to section 25a WpHG a
proportion of 0.01% (equals 13,726 voting rights) is held indirectly (chain
of controlled undertakings: Morgan Stanley & Co International Plc). The
instruments pursuant to section 25a WpHG are 'Cash-Settled Swaps'
(expiration date: 31 October 2013).

3) On 27 June 2012, Morgan Stanley Group (Europe) fell below the threshold
of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616
Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley Group
(Europe) held 0.07% of the voting rights in RHÖN-KLINIKUM AG (equals 99,226
voting rights).

From these voting rights a proportion of 0.00% (equals 0 voting rights) is
based on voting rights pursuant to sections 21, 22 WpHG.

In addition, a proportion of 0.06% (equals 85,500 voting rights) is based
on (financial/other) instruments pursuant to section 25 WpHG. From the
voting rights based on instruments pursuant to section 25 WpHG a proportion
of 0.06% (equals 85,500 voting rights) is held indirectly.

In addition, a proportion of 0.01% (equals 13,726 voting rights) is based
on (financial/other) instruments pursuant to section 25a WpHG. From the
voting rights based on instruments pursuant to section 25a WpHG a
proportion of 0.01% (equals 13,726 voting rights) is held indirectly (chain
of controlled undertakings: Morgan Stanley UK Group; Morgan Stanley & Co
International Plc). The instruments pursuant to section 25a WpHG are
'Cash-Settled Swaps' (expiration date: 31 October 2013).

4) On 27 June 2012, Morgan Stanley International Limited fell below the
threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger Leite
1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan Stanley
International Limited held 0.07% of the voting rights in RHÖN-KLINIKUM AG
(equals 99,226 voting rights).

From these voting rights a proportion of 0.00% (equals 0 voting rights) is
based on voting rights pursuant to sections 21, 22 WpHG.

In addition, a proportion of 0.06% (equals 85,500 voting rights) is based
on (financial/other) instruments pursuant to section 25 WpHG. From the
voting rights based on instruments pursuant to section 25 WpHG a proportion
of 0.06% (equals 85,500 voting rights) is held indirectly.

In addition, a proportion of 0.01% (equals 13,726 voting rights) is based
on (financial/other) instruments pursuant to section 25a WpHG. From the
voting rights based on instruments pursuant to section 25a WpHG a
proportion of 0.01% (equals 13,726 voting rights) is held indirectly (chain
of controlled undertakings: Morgan Stanley Group (Europe); Morgan Stanley
UK Group; Morgan Stanley & Co International Plc). The instruments pursuant
to section 25a WpHG are 'Cash-Settled Swaps' (expiration date: 31 October
2013).

5) On 27 June 2012, Morgan Stanley International Holdings Inc fell below
the threshold of 5% of the voting rights of RHÖN-KLINIKUM AG, Salzburger
Leite 1, 97616 Bad Neustadt a. d. Saale, Germany. On that date, Morgan
Stanley International Holdings Inc held 0.13% of the voting rights in
RHÖN-KLINIKUM AG (equals 184,726 voting rights).

From these voting rights a proportion of 0.06% (equals 85,500 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG

In addition, a proportion of 0.06% (equals 85,500 voting rights) is based
on (financial/other) instruments pursuant to section 25 WpHG. From the
voting rights based on instruments pursuant to section 25 WpHG a proportion
of 0.06% (equals 85,500 voting rights) is held indirectly.

In addition, a proportion of 0.01% (equals 13.726 voting rights) is based
on (financial/other) instruments pursuant to section 25a WpHG. From the
voting rights based on instruments pursuant to section 25a WpHG a
proportion of 0.01% (equals 13,726 voting rights) is held indirectly (chain
of controlled undertakings: Morgan Stanley International Limited; Morgan
Stanley Group (Europe); Morgan Stanley UK Group; Morgan Stanley & Co
International Plc). The instruments pursuant to section 25a WpHG are
'Cash-Settled Swaps' (expiration date: 31 October 2013).

6) On 27 June 2012, Morgan Stanley fell below the threshold of 5% of the
voting rights of RHÖN-KLINIKUM AG, Salzburger Leite 1, 97616 Bad Neustadt
a. d. Saale, Germany. On that date, Morgan Stanley held 0.37% of the voting
rights in RHÖN-KLINIKUM AG (equals 516,012 voting rights).

From these voting rights a proportion of 0.24% (equals 338,139 voting
rights) is based on voting rights pursuant to sections 21, 22 WpHG.

In addition, a proportion of 0.11% (equals 158,867 voting rights) is based
on (financial/other) instruments pursuant to section 25 WpHG. From the
voting rights based on instruments pursuant to section 25 WpHG a proportion
of 0.11% (equals 158,867 voting rights) is held indirectly.

In addition, a proportion of 0.01% (equals 19,006 voting rights) is based
on (financial/other) instruments pursuant to section 25a WpHG. From the
voting rights based on instruments pursuant to section 25a WpHG a
proportion of 0.01% (equals 13,726 voting rights) is held indirectly (chain
of controlled undertakings: Morgan Stanley International Holdings Inc;
Morgan Stanley International Limited; Morgan Stanley Group (Europe); Morgan
Stanley UK Group; Morgan Stanley & Co International Plc). The instruments
pursuant to section 25a WpHG are 'Cash-Settled Swaps' (expiration date: 31
October 2013) and 'Cash Settled Futures' (expiration date: 11 March 2013).

Bad Neustadt a.d. Saale, 5 July 2012

The Board of Management

___________________________________________________________________________

Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Phone: +49 9771 65 - 1318
Fax: +49 9771 99 - 1736



05.07.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Internet:     www.rhoen-klinikum-ag.com
 
End of Announcement                             DGAP News-Service